AIRS
AirSculpt Technologies, Inc. NASDAQ$3.44
Mkt Cap $242.7M
52w Low $1.51
18.4% of range
52w High $12.00
50d MA $2.47
200d MA $4.64
P/E (TTM)
-17.5x
EV/EBITDA
159.6x
P/B
2.3x
Debt/Equity
0.9x
ROE
-13.3%
P/FCF
173.0x
RSI (14)
—
ATR (14)
—
Beta
2.27
50d MA
$2.47
200d MA
$4.64
Avg Volume
2.6M
About
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; a…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | BMO | -0.03 | 0.02 | +180.0% | 2.73 | -5.5% | +16.1% | +13.6% | +7.7% | -0.4% | -0.7% | +26.0% | — |
| Nov 7, 2025 | BMO | -0.01 | -0.04 | -300.0% | 10.49 | -30.4% | -41.7% | -39.6% | -45.0% | -41.8% | -45.5% | -73.6% | — |
| Aug 1, 2025 | BMO | 0.02 | 0.02 | +0.0% | 6.61 | -16.8% | -10.4% | -8.8% | -8.9% | -7.0% | -6.2% | -5.0% | — |
| May 2, 2025 | BMO | -0.03 | -0.02 | +33.3% | 2.26 | +26.5% | +33.6% | +7.5% | +1.8% | +13.3% | +25.2% | +97.3% | — |
| Mar 14, 2025 | BMO | 0.02 | -0.08 | -500.0% | 2.94 | -13.6% | -2.7% | -10.5% | -11.9% | +1.7% | -4.4% | -39.5% | — |
| Nov 8, 2024 | BMO | -0.01 | -0.02 | -100.0% | 7.19 | +8.3% | +20.7% | +15.9% | +11.0% | +3.1% | -3.2% | -13.4% | — |
| Aug 9, 2024 | BMO | 0.13 | 0.09 | -30.8% | 3.94 | -18.8% | +1.0% | -12.9% | -6.3% | -4.8% | -1.3% | -5.8% | — |
| May 10, 2024 | BMO | 0.08 | 0.03 | -62.5% | 5.39 | -6.3% | -12.1% | -13.4% | -15.4% | -17.3% | -19.9% | -23.0% | — |
| Feb 27, 2024 | BMO | 0.11 | 0.01 | -90.9% | 6.31 | -13.5% | -2.1% | -4.1% | +0.0% | -0.5% | -5.5% | -2.7% | — |
| Nov 9, 2023 | BMO | 0.09 | 0.05 | -44.4% | 6.18 | +1.8% | -9.1% | -9.7% | -18.8% | -9.4% | -16.7% | -3.7% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $2.29 | $2.20 | -3.9% | +2.2% | -6.1% | -8.3% | -13.5% | -13.5% |
| Jan 17 | Piper Sandler | Maintains | Neutral → Neutral | — | $4.93 | $4.91 | -0.4% | +8.1% | +7.3% | +2.8% | +6.7% | +3.7% |
| Jan 6 | Piper Sandler | Maintains | Neutral → Neutral | — | $5.85 | $5.76 | -1.5% | +2.2% | +3.4% | +3.1% | +2.2% | -18.1% |
| May 14 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $4.67 | $4.75 | +1.7% | -2.4% | -4.5% | -7.5% | -0.2% | -7.7% |
| Nov 16 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $5.15 | $5.17 | +0.4% | -3.1% | -4.1% | +6.8% | +6.8% | +5.4% |
| Aug 22 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $7.67 | $7.79 | +1.6% | -2.1% | +4.6% | +1.3% | +3.4% | +3.9% |
| Aug 21 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $7.82 | $7.88 | +0.8% | -1.9% | -4.0% | +2.6% | -0.6% | +1.4% |
| Aug 1 | Raymond James | Maintains | Outperform → Outperform | — | $9.07 | $9.04 | -0.3% | +0.6% | -3.6% | -1.3% | -3.5% | -4.2% |
| Mar 13 | Raymond James | Maintains | Outperform → Outperform | — | $4.40 | $4.32 | -1.8% | +4.3% | +9.5% | +12.7% | +9.5% | +7.5% |
| Jan 17 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $4.98 | $4.97 | -0.2% | -6.0% | -7.8% | -1.2% | +0.8% | +6.6% |
Recent Filings
8-K
Unknown — 8-K Filing
AIRS maintained its 2026 guidance despite accounting principle adjustments, signaling management confidence in core business trajectory and reducing near-term investor concerns about guidance reliability.
Apr 6
8-K
Unknown — 8-K Filing
AirSculpt's fiscal 2025 results announcement will reveal revenue growth, profitability trends, and procedure volume metrics that determine whether the company can sustain its premium positioning in the competitive aesthetic surgery market.
Apr 2
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
AirSculpt's late annual report filing signals potential financial distress or operational challenges, raising investor concerns about transparency, compliance issues, and possible delisting risk if filings aren't caught up quickly.
Mar 16
8-K
Unknown — 8-K Filing
AirSculpt delayed its quarterly filing due to accounting complexities, signaling potential internal control weaknesses that could concern investors about financial reporting reliability and governance quality.
Mar 16
Data updated apr 24, 2026 4:58pm
· Source: massive.com